Literature DB >> 20642559

Palonosetron induced anaphylaxis in an adult female.

Yogendra K Gupta, Saravana P Shanmugam, Biswa M Padhy, Aman Goyal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642559      PMCID: PMC2909819          DOI: 10.1111/j.1365-2125.2010.03666.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Seizure associated with palonosetron.

Authors:  Alberto Zambelli; Paola Sagrada; Lorenzo Pavesi
Journal:  Support Care Cancer       Date:  2009-01-13       Impact factor: 3.603

2.  Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting.

Authors:  Andrew De Leon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-10

Review 3.  Adverse drug reactions in clinical practice: a causality assessment of a case of drug-induced pancreatitis.

Authors:  Andreea Farcas; Marius Bojita
Journal:  J Gastrointestin Liver Dis       Date:  2009-09       Impact factor: 2.008

4.  Hypersensitivity to intravenous ondansetron: a case report.

Authors:  Karishma K Mehra; Nithya J Gogtay; Rohan Ainchwar; Lata S Bichile
Journal:  J Med Case Rep       Date:  2008-08-14

5.  Palonosetron as an anti-emetic and anti-nausea agent in oncology.

Authors:  Matti S Aapro
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  5 in total
  2 in total

1.  Drug-induced anaphylactic reactions in Indian population: A systematic review.

Authors:  Tejas K Patel; Parvati B Patel; Manish J Barvaliya; C B Tripathi
Journal:  Indian J Crit Care Med       Date:  2014-12

2.  Palonosetron-Induced Anaphylaxis During General Anesthesia: A Case Report.

Authors:  Hyungjun Park; Kyunghwan Oh; Hoonhee Lee; Ji Hyang Lee; Sun Myoung Kang; So Young Park; Hyouk Soo Kwon; You Sook Cho; Hee Bom Moon; Tae Bum Kim
Journal:  Allergy Asthma Immunol Res       Date:  2017-01       Impact factor: 5.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.